In addition, using specific pharmacological inhibitors, it was demonstrated that Epac1 is required for migration and metastasis of pancreatic cancer, both in vitro [32, 58] and in vivo [30]. This evidence concerns the gene RAPGEF3 and pancreatic neoplasm.